NEW YORK, Oct. 8 (UPI) -- Almost 200,000 bottles of the anti-cholesterol drug Lipitor were recalled in August because of a smell, the U.S. pharmaceutical giant Pfizer said Thursday.
In a statement to CNN, Rick Chambers, a Pfizer spokesman, said the "uncharacteristic odor" involved bottles from another company. He said a total of seven batches of Lipitor totaling 191,000 bottles were recalled in the United States and Canada.
The U.S. Food and Drug Administration posted a recall notice Thursday.
"Pfizer has been working closely with the bottle supplier to determine the cause of the odor problem and to rapidly address it," Chambers said. "We don't anticipate a product shortage resulting from the recall."
He said the company received three complaints in July about the odor. Pfizer has determined there is no risk of medical problems to Lipitor users because of the smell.
